12 results
S-3
EX-1.2
PNT
POINT Biopharma Global Inc.
1 Jul 22
Shelf registration
4:13pm
consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified
8-K
EX-10.2
PNT
POINT Biopharma Global Inc.
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
of such indemnified party or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff
8-K/A
EX-2.1
a4udwiy3ecxi k5o
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-1.1
w6uy4wi4scir24 5hld
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm
8-K
EX-10.2
zrj52ialdwtz rjj0u
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm
S-1
EX-10.2
vewl50
15 Jun 20
IPO registration
5:28pm
S-1
EX-1.1
3x92igwhyy0fj i4
15 Jun 20
IPO registration
5:28pm
- Prev
- 1
- Next